These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 136768)

  • 21. Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein.
    Girard TJ; MacPhail LA; Likert KM; Novotny WF; Miletich JP; Broze GJ
    Science; 1990 Jun; 248(4961):1421-4. PubMed ID: 1972598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of tissue plasminogen activator by denatured proteins and fibrin clots: a possible additional role for plasminogen activator?
    Radcliffe R; Heinze T
    Arch Biochem Biophys; 1981 Oct; 211(2):750-61. PubMed ID: 6458244
    [No Abstract]   [Full Text] [Related]  

  • 23. Tissue factor activity of normal and neoplastic cells: quantitation and species specificity.
    Kadish JL; Wenc KM; Dvorak HF
    J Natl Cancer Inst; 1983 Mar; 70(3):551-7. PubMed ID: 6601203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.
    Welsch DJ; Novotny WF; Wun TC
    Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergism between full length TFPI and heparin: evidence for TFPI as an important factor for the antithrombotic activity of heparin.
    Valentin S; Ostergaard P; Kristensen H; Nordfang O
    Blood Coagul Fibrinolysis; 1992 Apr; 3(2):221-2. PubMed ID: 1318759
    [No Abstract]   [Full Text] [Related]  

  • 26. The tissue factor region that interacts with factor Xa in the activation of factor VII.
    Kirchhofer D; Eigenbrot C; Lipari MT; Moran P; Peek M; Kelley RF
    Biochemistry; 2001 Jan; 40(3):675-82. PubMed ID: 11170384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A sensitive, accurate assay for extrinsic pathway inhibitor (EPI) activity in rabbit plasma: paradoxical effect of excess exogenous factor X.
    Warr TA; Rao LV; Rapaport SI
    Thromb Res; 1990 Aug; 59(4):773-82. PubMed ID: 2080494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI.
    Lindahl AK; Abildgaard U; Larsen ML; Staalesen R; Hammer AK; Sandset PM; Nordfang O; Beck TC
    Thromb Res; 1991 Jun; 62(6):607-14. PubMed ID: 1926055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demonstration of a tissue factor causing the conversion of native plasminogen to a more reactive form.
    Astrup T; Feddersen F
    Thromb Res; 1975 Sep; 7(3):501-4. PubMed ID: 1188852
    [No Abstract]   [Full Text] [Related]  

  • 30. [Disseminated intravascular coagulation].
    Amir J
    Harefuah; 1972 Jul; 83(1):29-32. PubMed ID: 4264530
    [No Abstract]   [Full Text] [Related]  

  • 31. Expression of procoagulant activity in a human monocyte-like cell line.
    Ewan VA; Edwards RL; Rickles FR
    J Lab Clin Med; 1983 Mar; 101(3):401-10. PubMed ID: 6338139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the coagulation factor VII by tissue thromboplastin and calcium.
    Osterud B; Berre A; Otnaess AB; Bjorklid E; Prydz H
    Biochemistry; 1972 Jul; 11(15):2853-7. PubMed ID: 5041901
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of Warfarin and factor VII on tissue procoagulant activity and pulmonary seeding.
    Francis JL; Carty N; Amirkhosravi M; Loizidou M; Cooper A; Taylor I
    Br J Cancer; 1992 Mar; 65(3):329-34. PubMed ID: 1558784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of coagulation by a multivalent Kunitz-type inhibitor.
    Broze GJ; Girard TJ; Novotny WF
    Biochemistry; 1990 Aug; 29(33):7539-46. PubMed ID: 2271516
    [No Abstract]   [Full Text] [Related]  

  • 35. Activation of plasminogen by tissue activator is increased specifically in the presence of certain soluble fibrin(ogen) fragments.
    Verheijen JH; Nieuwenhuizen W; Wijngaards G
    Thromb Res; 1982 Aug; 27(4):377-85. PubMed ID: 6890721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of factor IX in tissue thromboplastin induced coagulation.
    van den Besselaar AM; Ram IE; Alderkamp GH; Bertina RM
    Thromb Haemost; 1982 Aug; 48(1):54-8. PubMed ID: 6982540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of the initiation of coagulation by factor VII.
    Nemerson Y
    Haemostasis; 1983; 13(3):150-5. PubMed ID: 6350119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alternative pathways of thromboplastin-dependent activation of human factor X in plasma.
    Marlar RA; Griffin JH
    Ann N Y Acad Sci; 1981; 370():325-35. PubMed ID: 6943963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant thromboplastin is slightly more sensitive to factor VII Padua than standard thromboplastins of human origin.
    Girolami A; Sartori MT; Steffan A; Fadin MA
    Blood Coagul Fibrinolysis; 1993 Jun; 4(3):497-8. PubMed ID: 8329576
    [No Abstract]   [Full Text] [Related]  

  • 40. TISSUE EXTRACTS AND THEIR SENSITIVITY TO FACTOR VII AND FACTOR X.
    DENSON KW
    Thromb Diath Haemorrh; 1964 Apr; 11():146-54. PubMed ID: 14171582
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.